Genetics watchdog.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The British House of Commons has produced a telling document on the future of genetics.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In its recent report Human Reproductive Technologies and the Law, the House of Commons' Select Committee on Science and Technology insisted that the United Kingdom 'does not take a purely insular view' on sex selection but to carefully consider the impact on other countries before allowing changes to current legislation. True, no country is an island, not even the British Isles. Still, outlawing a harmless practice in Great Britain because of its alleged harmful effects in other countries is bad public policy.
Following the review of the Human Fertilisation and Embryology Act by the House of Commons select committee on science and technology (see Bulletin 208), the Department of Health issued a consultation paper on its proposals to change the law. Although the consultation period will be over before this issue is published, it seems worth reprinting the summary of the paper to record the department's thinking on a variety of issues.
The House of Commons Science & Technology Committee has reviewed the Human Fertilisation and Embryology Act. It considered a) the balance between legislation, regulation and reproductive freedom; b) the role of Parliament in human reproductive technologies; and c) the foundation, adequacy and appropriateness of the ethical framework for legislation. It also considered the Act itself and the workings of the Human Fertilisation and Embryology Authority. Its report is written from a very liberal perspective, but is a very thorough overview of current issues and debate in the field. There follow, slightly abridged, the conclusions and recommendations of the 200-page report.
The above committee is one of Parliament's select committees that undertake enquiries of considerable depth in their particular fields. Its latest enquiry looked at the MRC in general, and also specifically at how it is handling the Biobank project. Its general findings are scathing of the MRC's performance and mismanagement of its funds, concluding that 'the anger of the research community at MRC's funding problems is not only understandable but entirely justified.' The following are the committee's conclusions and recommendations on Biobank--the collection of blood samples, lifestyle details and medical histories from 500,000 middle-aged Britons, and its general conclusions.